Publication Details

Pubmed29661116
Title: CRISPR/Cas9-Targeted Deletion of Polyglutamine in Spinocerebellar Ataxia Type 3-Derived Induced Pluripotent Stem Cells.
Year: 2018
DOI: https://doi.org/10.1089/scd.2017.0209
First Author: Ouyang
Experimental setup: affinity chromatography technology (Biogrid)
Throughput: Low Throughput (Biogrid)

Interactions

1 interaction
InteractorPartnerSourcesLink
ATX3_HUMANUBC_HUMANBioGRIDdetails